95 related articles for article (PubMed ID: 28062409)
1. D-mannose: a novel prognostic biomarker for patients with esophageal adenocarcinoma.
Gu J; Liang D; Pierzynski JA; Zheng L; Ye Y; Zhang J; Ajani JA; Wu X
Carcinogenesis; 2017 Feb; 38(2):162-167. PubMed ID: 28062409
[TBL] [Abstract][Full Text] [Related]
2. Identification of Serum Markers of Esophageal Adenocarcinoma by Global and Targeted Metabolic Profiling.
Sanchez-Espiridion B; Liang D; Ajani JA; Liang S; Ye Y; Hildebrandt MA; Gu J; Wu X
Clin Gastroenterol Hepatol; 2015 Oct; 13(10):1730-1737.e9. PubMed ID: 25998788
[TBL] [Abstract][Full Text] [Related]
3. Esophageal cancer metabolite biomarkers detected by LC-MS and NMR methods.
Zhang J; Bowers J; Liu L; Wei S; Gowda GA; Hammoud Z; Raftery D
PLoS One; 2012; 7(1):e30181. PubMed ID: 22291914
[TBL] [Abstract][Full Text] [Related]
4. Serum Glycoprotein Biomarker Discovery and Qualification Pipeline Reveals Novel Diagnostic Biomarker Candidates for Esophageal Adenocarcinoma.
Shah AK; Cao KA; Choi E; Chen D; Gautier B; Nancarrow D; Whiteman DC; Saunders NA; Barbour AP; Joshi V; Hill MM
Mol Cell Proteomics; 2015 Nov; 14(11):3023-39. PubMed ID: 26404905
[TBL] [Abstract][Full Text] [Related]
5. Evaluation of a 4-protein serum biomarker panel-biglycan, annexin-A6, myeloperoxidase, and protein S100-A9 (B-AMP)-for the detection of esophageal adenocarcinoma.
Zaidi AH; Gopalakrishnan V; Kasi PM; Zeng X; Malhotra U; Balasubramanian J; Visweswaran S; Sun M; Flint MS; Davison JM; Hood BL; Conrads TP; Bergman JJ; Bigbee WL; Jobe BA
Cancer; 2014 Dec; 120(24):3902-13. PubMed ID: 25100294
[TBL] [Abstract][Full Text] [Related]
6. Circulating Tumor Cells in the Adenocarcinoma of the Esophagus.
Gallerani G; Fabbri F
Int J Mol Sci; 2016 Aug; 17(8):. PubMed ID: 27527155
[TBL] [Abstract][Full Text] [Related]
7. HLA-DR expression in tumor epithelium is an independent prognostic indicator in esophageal adenocarcinoma patients.
Dunne MR; Michielsen AJ; O'Sullivan KE; Cathcart MC; Feighery R; Doyle B; Watson JA; O'Farrell NJ; Ravi N; Kay E; Reynolds JV; Ryan EJ; O'Sullivan J
Cancer Immunol Immunother; 2017 Jul; 66(7):841-850. PubMed ID: 28315927
[TBL] [Abstract][Full Text] [Related]
8. Evaluation of miR-21 and miR-375 as prognostic biomarkers in esophageal cancer.
Winther M; Alsner J; Tramm T; Baeksgaard L; Holtved E; Nordsmark M
Acta Oncol; 2015; 54(9):1582-91. PubMed ID: 26481465
[TBL] [Abstract][Full Text] [Related]
9. Profiles of autophagy-related genes in esophageal adenocarcinoma.
Zhu L; Dong L; Feng M; Yang F; Jiang W; Huang Z; Liu F; Wang L; Wang G; Li Q
BMC Cancer; 2020 Oct; 20(1):943. PubMed ID: 32998713
[TBL] [Abstract][Full Text] [Related]
10. Evaluation of Ficolin-3 as a Potential Prognostic Serum Biomarker in Chinese Patients with Esophageal Cancer.
Li Q; Lin Y
Genet Test Mol Biomarkers; 2019 Aug; 23(8):565-572. PubMed ID: 31373851
[No Abstract] [Full Text] [Related]
11. Primary tumor microRNA signature predicts recurrence and survival in patients with locally advanced esophageal adenocarcinoma.
Matsui D; Zaidi AH; Martin SA; Omstead AN; Kosovec JE; Huleihel L; Saldin LT; DiCarlo C; Silverman JF; Hoppo T; Finley GG; Badylak SF; Kelly RJ; Jobe BA
Oncotarget; 2016 Dec; 7(49):81281-81291. PubMed ID: 27793030
[TBL] [Abstract][Full Text] [Related]
12. Protein coding gene CRNKL1 as a potential prognostic biomarker in esophageal adenocarcinoma.
Li Z; Yao Q; Zhao S; Wang Z; Li Y
Artif Intell Med; 2017 Feb; 76():1-6. PubMed ID: 28363284
[TBL] [Abstract][Full Text] [Related]
13. Clinicopathological and prognostic significance of epidermal growth factor receptor overexpression in patients with esophageal adenocarcinoma: a meta-analysis.
Guo YM; Yu WW; Zhu M; Guo CY
Dis Esophagus; 2015; 28(8):750-6. PubMed ID: 24961755
[TBL] [Abstract][Full Text] [Related]
14. Whole-miRNome profiling identifies prognostic serum miRNAs in esophageal adenocarcinoma: the influence of Helicobacter pylori infection status.
Zhai R; Wei Y; Su L; Liu G; Kulke MH; Wain JC; Christiani DC
Carcinogenesis; 2015 Jan; 36(1):87-93. PubMed ID: 25381453
[TBL] [Abstract][Full Text] [Related]
15. Profiling of circulating microRNAs in patients with Barrett's esophagus and esophageal adenocarcinoma.
Bus P; Kestens C; Ten Kate FJ; Peters W; Drenth JP; Roodhart JM; Siersema PD; van Baal JW
J Gastroenterol; 2016 Jun; 51(6):560-70. PubMed ID: 26585599
[TBL] [Abstract][Full Text] [Related]
16. Serum Levels of 25-Hydroxyvitamin D at Diagnosis Are Not Associated with Overall Survival in Esophageal Adenocarcinoma.
Loehrer E; Betensky RA; Giovannucci E; Su L; Shafer A; Hollis BW; Christiani DC
Cancer Epidemiol Biomarkers Prev; 2019 Aug; 28(8):1379-1387. PubMed ID: 31186263
[TBL] [Abstract][Full Text] [Related]
17. Development of a metabolites risk score for one-year mortality risk prediction in pancreatic adenocarcinoma patients.
Fontana A; Copetti M; Di Gangi IM; Mazza T; Tavano F; Gioffreda D; Mattivi F; Andriulli A; Vrhovsek U; Pazienza V
Oncotarget; 2016 Feb; 7(8):8968-78. PubMed ID: 26840268
[TBL] [Abstract][Full Text] [Related]
18. Global and targeted serum metabolic profiling of colorectal cancer progression.
Long Y; Sanchez-Espiridion B; Lin M; White L; Mishra L; Raju GS; Kopetz S; Eng C; Hildebrandt MAT; Chang DW; Ye Y; Liang D; Wu X
Cancer; 2017 Oct; 123(20):4066-4074. PubMed ID: 28640361
[TBL] [Abstract][Full Text] [Related]
19. LC-MS/MS determination of d-mannose in human serum as a potential cancer biomarker.
White L; Ma J; Liang S; Sanchez-Espiridion B; Liang D
J Pharm Biomed Anal; 2017 Apr; 137():54-59. PubMed ID: 28092855
[TBL] [Abstract][Full Text] [Related]
20. Survival benefit of surgery with radiotherapy vs surgery alone to patients with T2-3N0M0 stage esophageal adenocarcinoma.
Song Y; Tao G; Guo Q; Yang X; Zhu H; Wang W; Sun X
Oncotarget; 2016 Apr; 7(16):21347-52. PubMed ID: 26870996
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]